3rd Quarter - Report

ALKERMES, INC. for ALKERMES, INC.

Period 3rd Quarter 2012 Filed Oct 18, 2012 Signed by Kathryn L. Biberstein; General Counsel

Official filing
Firm
ALKERMES, INC.
Client
ALKERMES, INC.
Income
—
Expenses
$60,293
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discuss need for educational resources and status of Vivitrol in public health

LobbyistCovered position, as disclosed
ROBERT FORMAN —

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.